| Market Cap | ₹4,807Cr |
| ROE | 0.00% |
| P/E Ratio(TTM) | 71.61 |
| EPS(TTM) | 6.69 |
| P/B Ratio | 5.05 |
| Dividend Yield | 0.00% |
| Industry P/E | 60.51 |
| Book Value | 94.78 |
| Debt to Equity | 0.36 |
| Face Value | 2 |
| Parent Organisation | Nephrocare Health Services |
| NSE Symbol | NEPHROPLUS |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Max Healthcare Institute | NA (0.00%) | 75.27 | ||
| Apollo Hospitals Enterprise | NA (0.00%) | 58.89 | ||
| Fortis Healthcare | NA (0.00%) | 66.57 | ||
| Narayana Hrudayalaya | NA (0.00%) | 46.00 |